Olfactory Bulb Volume —A Novel Preclinical Biomarker for Smell Loss and Neurodegenerative Disease

Neurodegenerative disorders, such as Alzheimer dementia and Parkinson disease, are disabling diseases that present a burden on society that rivals the costs of cancer and heart disease. Although current therapies are often unsuccessful at reversing the progression of these diseases, early detection in patients who are at risk of neurodegenerative disease could allow for timely interventions to delay and minimize the loss of brain function over time.
Source: JAMA Otolaryngology - Head and Neck Surgery - Category: ENT & OMF Source Type: research